Survey results indicate that the current regulatory approval pathway for excipients creates a challenge for the use of novel excipients.
Michael Rashed
Advertisement
Articles by Michael Rashed
Advertisement
Latest Updated Articles
USP Novel Excipients Survey: Stakeholders’ Views on the Current State of Excipient InnovationPublished: June 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
2
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
3
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
4
Sustainability and Stability in Excipients
5
